Table 4.

Univariable and Multivariable Competing Risks Regression for Distant Metastases

		Univariable DM			Multivariable DM			Multi: Including NCCN
		HR	[95% CI]	p-value	HR	[95% CI]	p-value	HR	[95% CI]	p-value
Biopsy Result	Positive	2.78	[1.83 – 4.22]	<.001	2.59	[1.63 – 4.13]	<.001	2.47	[1.53 – 3.99]	<.001
	Negative	REF			REF			REF
Gleason Score	>=7	3.77	[2.15 – 6.61]	<.001	3.20	[1.80 – 5.70]	<.001	3.15	[1.56 – 6.36]	0.001
	<=6	REF			REF			REF
Pre-RT PSA (ng/mL)	>=20	1.69	[1.02 – 2.79]	0.023	1.43	[0.86 – 2.39]	0.17	1.15	[0.63 – 2.12]	0.65
	10–20	0.81	[0.49 – 1.34]		0.77	[0.47 – 1.28]	0.31	0.79	[0.47 – 1.34]	0.38
	0–10	REF			REF			REF
T-Stage	T3	1.28	[0.74 – 2.21]	0.37	1.06	[0.59 – 1.89]	0.85	0.87	[0.46 – 1.65]	0.67
	T1-T2	REF			REF			REF
Hormones	No	0.87	[0.57 – 1.32]	0.51	0.85	[0.54 – 1.33]	0.47	0.91	[0.56 – 1.47]	0.70
	Yes	REF			REF			REF
NCCN Risk Score	High	3.56	[1.39 – 9.09]	<.001	---			1.30	[0.36 – 4.69]	0.69
	Medium	1.72	[0.66 – 4.49]		---			0.81	[0.26 – 2.57]	0.72
	Low	REF			---			REF